Back to Search
TAYLOR TWIGGS SUTTER MD
MD
Obstetrics & Gynecology Physician
NPI: 1205331774IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
01088070A(IN)38979(AL)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Education
INDIANA UNIVERSITY SCHOOL OF MEDICINE
Class of 2018
Research & Publications (20)
Cutting wires cuts errors. Dispensing mistakes drop when a wireless network brings records to the bedside.
PMID 16173638·Healthc Inform·2005
8-other
Protection against aflatoxin B1-induced cytotoxicity by expression of the cloned aflatoxin B1-aldehyde reductases rat AKR7A1 and human AKR7A3.
PMID 18416522·Chem Res Toxicol·2008
7-preclinical
Overexpression of cyclin E protein is closely related to the mutator phenotype of colorectal carcinoma.
PMID 12355212·Int J Colorectal Dis·2002
8-other
Multiple comparisons model-based clustering and ternary pattern tree numerical display of gene response to treatment: procedure and application to the preclinical evaluation of chemopreventive agents.
PMID 12516961·Mol Cancer Ther·2002
7-preclinical
EGF receptor signaling blocks aryl hydrocarbon receptor-mediated transcription and cell differentiation in human epidermal keratinocytes.
PMID 19255421·Proc Natl Acad Sci U S A·2009
8-other
Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice.
PMID 19386581·Carcinogenesis·2009
7-preclinical
Chemical genomics of cancer chemopreventive dithiolethiones.
PMID 19126641·Carcinogenesis·2009
7-preclinical
Transgenic expression of aflatoxin aldehyde reductase (AKR7A1) modulates aflatoxin B1 metabolism but not hepatic carcinogenesis in the rat.
PMID 19168568·Toxicol Sci·2009
7-preclinical
Analyzing microarray data with transitive directed acyclic graphs.
PMID 19226664·J Bioinform Comput Biol·2009
8-other
CYP1B1 is not a major determinant of the disposition of aromatase inhibitors in epithelial cells of invasive ductal carcinoma.
PMID 18256205·Drug Metab Dispos·2008
7-preclinical
Quantification of urinary aflatoxin B1 dialdehyde metabolites formed by aflatoxin aldehyde reductase using isotope dilution tandem mass spectrometry.
PMID 18266327·Chem Res Toxicol·2008
7-preclinical
Microarray analysis reveals distinctive signaling between the bed nucleus of the stria terminalis, nucleus accumbens, and dorsal striatum.
PMID 17911379·Physiol Genomics·2008
4-observational
Toxicogenomic analysis of gender, chemical, and dose effects in livers of TCDD- or aroclor 1254-exposed rats using a multifactor linear model.
PMID 18178546·Toxicol Sci·2008
7-preclinical
Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study.
PMID 17968031·Cancer Res·2007
8-other
Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol.
PMID 18056439·Cancer Res·2007
8-other
Uncertainties related to the assignment of a toxic equivalency factor for 1,2,3,4,6,7,8,9-octachlorodibenzo-p-dioxin.
PMID 16460856·Regul Toxicol Pharmacol·2006
6-review
Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.
PMID 16675129·Biochim Biophys Acta·2006
6-review
Regioselective 2-hydroxylation of 17beta-estradiol by rat cytochrome P4501B1.
PMID 16893557·Toxicol Appl Pharmacol·2006
7-preclinical
Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women.
PMID 16847423·Pharmacogenet Genomics·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 13420 N MERIDIAN ST STE 300
CARMEL, IN 46032 - Phone
- (317) 582-7248
Quick Facts
- NPI
- 1205331774
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 3
- Years in Practice
- 8
- Publications
- 20
Are you this provider?
Claim Your Profile